NICE Pathways (2012) Treatment for Non-Small Cell Lung Cancer. http://pathways.nice.org.uk/path
ways/lung-cancer#path=view%3A/pathways/lung-cancer/treatment-for-non-small-cell-lung-cancer.
xml&content=view-node%3Anodes-first-line-and-maintenance-chemotherapy-for-advanced-or-meta
static-non-small-cell-lung-cancer

has been cited by the following article:

• TITLE: Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

  AUTHORS: Karin R. Purshouse

  KEYWORDS: Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development

  JOURNAL NAME: Advances in Lung Cancer, Vol.3 No.3, August 22, 2014

  ABSTRACT: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.